Abstract Inflammation is in part defined by the transient upregulation of cell adhesion molecules on the surface of endothelial cells (ECs) in response to cytokines. We hypothesized that liposomes with a complementary surface presentation of antibodies to the pattern of molecules on the EC surface may enhance targeting. We quantified the expression of vascular cell adhesion molecule-1 (VCAM1) and endothelial leukocyte cell adhesion molecule-1 (E-selectin) on ECs upon exposure to either tumor necrosis factor-α (TNF-α) or interleukin-1α (IL-1α) as a function of time. Liposomes, composed of 95 mol% dioleoyl phosphatidylcholine (DOPC) and 5 mol% dodecanyl phosphatidylethanolamine (N-dod-PE), were prepared by conjugating different molar ratios of antibodies against VCAM1 (aVCAM1) and E-selectin (aE-selectin). Increased binding was observed when immunoliposomes complemented the presentation of VCAM1:E-selectin expressed on TNF-α activated ECs. The 1:1 aVCAM1:aE-selectin liposomes had maximal binding at both 6 and 24 h on IL-1α activated ECs due to differences in molecular organization. The results demonstrate that liposomes targeting to inflamed endothelium may be optimized by exploiting the dynamic expression of VCAM1 and E-selectin on the EC surface. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65
Introduction
The transient expression of cell adhesion molecules on endothelial cells (ECs) presents a targeting opportunity for inflamed endothelium [1] [2] [3] . Intercellular cell adhesion molecule-1 (ICAM1), endothelial leukocyte adhesion molecule-1 (E-selectin), and vascular cell adhesion molecule-1 (VCAM1) are upregulated on ECs upon activation with inflammatory cytokines [4] [5] [6] . Each of these molecules has been investigated for targeting [7] [8] [9] ; however, no binding studies have correlated the ratio of antibodies on drug delivery vehicles with the presentation of target molecules on ECs.
Targeting multiple, transiently-upregulated cell adhesion molecules on ECs may amplify binding specificity and cellular uptake of drug delivery vehicles. Microbubble contrast agents conjugated with dual targeting antibodies against VCAM1 and P-selectin bound almost twice as effectively as single-targeting microbubbles [10] . Similarly, the adhesion of microspheres bearing antibodies against ICAM1 (aICAM1) and sialyl Lewis x , a selectin ligand, was dependent on the concentration of both ligands [11, 12] . Our previous reports also demonstrated that the antibody ratio (aICAM1:aE-selectin) and lipid mobility influenced cellular binding [13] .
These observations, however, did not account for the fact that the cell surface is spatiotemporally dynamic. Cell adhesion molecules, such as E-selectin and ICAM1, have been reported to cluster following their engagement in a cytokine or shear-induced response [14] .
Clustering of ICAM1 and E-selectin in lipid raft microdomains is required for subsequent cell signaling and gene expression [15, 16] . Binding of liposomes, targeted to ICAM1 and E-selectin, was reduced to the non-specific level when lipid raft formation was inhibited by addition of a cholesterol chelation agent, methyl-β-cyclodextrin. [17] . These reports clearly demonstrate the importance of molecular organization on the EC surface in liposome targeting. Click here to view linked References   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 In addition to clustering, the expression of cell adhesion molecules on ECs changes temporally after exposure to cytokines. Several studies have reported the time-course expression of cell adhesion molecules in response to different inflammatory cytokines. Scholz et al. showed that interleukin-1β (IL-1-induced VCAM1 and E-selectin expression regressed after 8 h while ICAM1 was maintained for 72 h [18] . With IL-1, E-selectin expression peaked at 6 h whereas platelet endothelial cell adhesion molecule-1 (PECAM1) reached a plateau after 12 h [19] . The expression trend for each cell adhesion molecule corresponds to the inflammatory response, where they mediate neutrophil rolling, adhesion, arrest and transmigration [20] .
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Changes in the endothelial phenotype may be important in the design of drug delivery vehicles that target the endothelium. Targeting of drug delivery vehicles to inflamed ECs may be tailored to the latent stage of the immune response, resulting in consistent delivery of therapeutic agents at the target site ( Figure 1 ).
In this report, we characterized the expression of VCAM1 and E-selectin as a function of time in response to IL-1 and TNF-. Liposomes were modified with different molar ratios of aVCAM1:aE-selectin to evaluate optimum binding to activated ECs as a function of time. Drug delivery vehicles designed to target inflamed endothelium may benefit from understanding the temporal dynamics of molecules expressed on the EC surface. 
Liposome preparation
Unilamellar liposomes were prepared by the extrusion method as previously described [13] . A mixture of DOPC:N-dod-PE (95:5 mol%) in chloroform was dried in a rotary evaporator under reduced pressure. The lipids were then dissolved in a mixture of DMSO:EtOH (7:3 v/v). 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Lipid mixtures (0.3 mL) were injected in 3 mL PBS (pH 7.4) with or without rhodamineconjugated dextran (1 mg/mL) while being agitated at 650 rpm with a stir bar to yield 50 mM lipid. The multilamellar vesicles were subjected to 10 freeze-thaw cycles (utilizing liquid nitrogen) prior to extrusion. Large unilamellar vesicles were prepared by utilizing a LIPEX TM extruder (Northern Lipids, Burnaby, Canada). Vesicles were extruded 10 times through a 200 nm The concentration of lipid in solution was determined by a phosphate assay as previously described [13] . Briefly, a diluted liposome sample was ashed with 0.2 mL sulfuric acid (10% v/v) at 200°C for 1 h, followed by addition of 50 l hydrogen peroxide (30% v/v) and further heating at 200°C for 40 min. After the sample was cooled down to RT, 480 mL deionized water and 0.5 mL of color reagent (0.5% w/v ammonium molybdate, 2 % w/v ascorbic acid) were added to each sample followed by heating at 45°C for 20 min. The samples were read at 820 nm using a Spectramax Plus 384 spectrophotometer (Molecular Devices, Sunnyvale, CA). A calibration curve was prepared with known phosphate quantities.
Preparation of antibody-labeled liposomes and microspheres
Mouse aVCAM1 and mouse aE-selectin mAbs were conjugated to liposomes via the Ndod-PE anchor. EDC (2 mg) and NHS (3 mg) were added to 1 mol lipid (liposomes) in PBS   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Cell culture Human umbilical vein endothelial cells (ECs) were grown in endothelial growth medium-2 (EGM-2) with supplements as described by the distributor (Lonza, Allendale, NJ). Cells were maintained at 37°C in a humidified incubator with 5% CO 2 and used for experiments at passages 2-5. Growth medium was changed the day after cell seeding and every other day thereafter.
VCAM1 and E-selectin immunostaining
ECs (2x10 5 cells) were seeded on 18x18 mm 2 coverslips in 6-well plates with 2 mL media (VWR, West Chester, PA) and cultured overnight at 37°C. Cells were incubated with IL-1 at 5 ng/mL or TNF- at 20 ng/mL in fresh EGM-2 media the next day for 6 h or 24 h. After medium was removed, cells were rinsed with PBS three times and fixed with 4% formaldehyde in PBS at RT for 15 min followed by washing with PBS. Samples were blocked with 1% BSA in PBS (1% BSA) at 4°C for 1 h. Samples were then stained with aVCAM1 and aE-selectin mAbs 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65
VCAM1 and E-selectin expression
VCAM1 and E-selectin expression by ECs was evaluated by flow cytometry after 1, 6, 12, and 24 h incubations with either IL-1 (5 ng/mL) or TNF- (20 ng/mL). Quantification of the density of molecules on the surface was determined using Quantum™ Simply Cellular ® microbeads. After ECs were activated with IL-1 or TNF-, 10 6 cells were collected from a 6well plate, spun down, and resuspended with ice cold 1% BSA in PBS. ECs were rinsed 3 times through suspension-spin cycles and blocked with 1% BSA in PBS for 30 min in an ice bath. ECs were incubated with mouse anti-human VCAM1 and sheep anti-human E-selectin mAbs (1 mL, 10 ng/mL) for 30 min in an ice bath. After rinsing with 1% BSA in PBS 3 times to remove free mAbs, ECs were stained with FITC-conjugated goat anti-mouse and TRITC-conjugated rabbit anti-sheep secondary antibodies for 30 min in an ice bath. ECs were finally rinsed with 1% BSA in PBS 3 times, resuspended in PBS, and analyzed by flow cytometry.
Liposome uptake by ECs
Liposome binding by ECs was analyzed using flow cytometry as previously described [21, 22] . ECs were seeded in 6-well plates (3x10 5 cells/well) and allowed to adhere overnight.
After activation with IL-1 or TNF- for 6 h or 24 h, ECs were incubated overnight at 37°C with: (1) dextran-loaded nonspecific (IgG 1 ) liposomes; and (2) dextran-loaded liposomes conjugated with different ratios of aVCAM1:aE-selectin mAbs. The concentration used was 1 μmol lipid/10 6 cells.
Treated ECs were washed with PBS, harvested using trypsin/EDTA solution, and collected in a polystyrene culture tube. Cells were washed with PBS three times. Liposomes were not detected by fluorescence in the trypsin solution used to remove ECs [17] . Binding data   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 were acquired using an LSRII flow cytometry (BD Immunocytometry Systems, San Jose, CA) and analyzed with WEASEL software developed by WEHI (Parkville, Australia). The fold-over isotype value was calculated by dividing the mean fluorescence intensity for liposomes conjugated with aVCAM:aE-selectin by that of the isotype-conjugated liposomes. Significant differences in liposome uptake were evaluated using a 2-way ANOVA analysis. A P value less than 0.05 was considered statistically significant. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 
Results and Discussion

Characterization of liposomes
Liposomes were prepared from 95 mol% DOPC and 5 mol% N-dod-PE . The diameters of unconjugated DOPC:N-dod-PE liposomes were 205 ± 5 nm, as determined from dynamic light scattering. After conjugation with aVCAM1 and aE-selectin, liposome diameters increased to 223 ± 3 nm; the diameters were similar for all liposome formulations. The antibody density and aVCAM1:aE-selectin ratio were determined using standardized microbeads ( Table 1 ). The average antibody density for 1:0 aVCAM:aE-selectin ratio was 6703 ± 379 molecules/m 2 or 842 ± 47 molecules/liposome; this is comparable to other reports (7000 molecules/m 2 [32] , 4100 molecules/m 2 [33] ). 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 65
VCAM1 and E-selectin changes temporally
Complementary liposomes increase cellular binding
Liposomes with different ratios of aVCAM1:aE-selectin were incubated with cytokineactivated ECs to observe the sensitivity of EC surface expression to liposome antibody presentation. ECs are known to transiently express VCAM1 and E-selectin in response to cytokines; this reproducible gene expression profile makes ECs a good model system for studying how changes in the EC surface presentation affects liposome targeting [23] . EC surface expression of VCAM1 and E-selectin was similar for IL-1 and TNF-, approximately 1:20 and 1:1 VCAM1:E-selectin at 6 and 24 h, respectively (Figure 3 ). EC binding of dextranencapsulating liposomes was evaluated by flow cytometry as a function of the aVCAM1:aEselection ratio (1:0, 1:1, 1:4, 1:8, and 0:1) and activation time (6 and 24 h) ( Figure 4A and 4B) .
At early times, E-selectin is highly expressed in activated ECs; thus, liposomes presenting more aE-selectin exhibit greater binding. Liposome binding increased from 1.7-fold to 3.7-fold relative to IgG presenting liposomes, when the aVCAM1:aE-selectin ratio was reduced from 1:0 to 1:8 on TNF-α activated ECs, respectively. At later times, the increase in VCAM1 density on TNF-α activated ECs resulted in greater binding of liposomes with a comparable presentation of aVCAM1:aE-selectin. Liposome binding at 24 h peaked at 1:1 aVCAM1:aE-selectin; this was 2.3-fold greater than 1:0 and 0:1 aVCAM1:aE-selectin liposome formulations and ~4-fold greater than the IgG conjugated liposome control. Cellular binding at all non-optimal ratios were significantly lower than the 1:1 aVCAM1:aE-selectin liposomes (p < 0.001).
For TNF-α, maximal binding was achieved when liposomes complemented the expression of VCAM1 and E-selectin on the EC surface; peak binding was observed at 1:8 and 1:1 aVCAM1:aE-selectin at 6 and 24 h, respectively (Figure 4 ). This was analogous to the ratio 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 of VCAM1:E-selectin expressed on the EC surface ( Figure 3 ). No significant difference in binding was observed between the 1:20 and 0:1 aVCAM1:aE-selectin liposome formulation except for ECs activated for 24 h with TNF-α (p < 0.05) ( Supplementary Figure 1A and 1B ).
Complementary liposomes had significantly higher binding than the 1:0 and 0:1 aVCAM1:aEselectin liposomes, confirming a cooperative interaction between colocalized VCAM1 and Eselectin [17] . (Figure 2A ). Although the average ratios of VCAM1:E-selectin are similar between TNF-α and IL-1α, the organization of the molecules may differ upon assembly within lipid rafts. We have previously reported that the organization of cell adhesion molecules within lipid rafts is critical for achieving cooperative binding of liposomes to activated ECs [17] .
EC surface expression is used to regulate leukocyte-EC interactions [2, 26] . E-selectin, whose expression is restricted on activated ECs, mediates the homing and rolling of leukocytes during the inflammatory response [27] . VCAM1 is virtually absent on normal endothelium; its expression is more widely expressed by cytokine-activated endothelial cells [34, 35. Recently, VCAM1 expression has been shown to cluster primarily on the apical surface of ECs [23, 31] .
The upregulation of VCAM1 and E-selectin is not enough to target inflamed ECs. The   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 organization of the cell adhesion molecules is important in regulating liposome binding and cellcell interactions.
Our results suggest that liposomes, designed to be complementary to the activated EC surface at a particular time, may be optimized to deliver agents at specific stages of inflammation. Liposome binding is dependent on the density and organization expressed of molecules on ECs, which is regulated by the exposure time and type of cytokine.
In this report, we have demonstrated that liposomes with a complementary surface presentation to ECs resulted in increased binding relative to liposomes presenting either aVCAM1 or aE-selectin alone. Transiently-upregulated cell adhesion molecules may be exploited to design drug delivery vehicles that will have sustained binding to activated ECs.
Conclusions
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